Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel DiseasesKate D. Lynch, Cynthia Levy, Satish Keshav et al.|Clinical Gastroenterology and Hepatology|2019Cited by 104